Harvard Bioscience makes laboratory instruments and software used in life science research and preclinical drug testing. It last closed at $8.66 on Nov 20, down 0.23% on the day. The next earnings report for HBIO is expected around Tue, Feb 9, 2027. For the quarter ended Sep 2026, HBIO reported EPS of -$0.58 on revenue of $22.2M, with revenue up 7.8% from a year ago. Over its last 8 reports the stock moved an average of 8.9% the session after earnings. Over the last 12 months HBIO insiders bought $202K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is HBIO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold HBIO.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on HBIOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
HBIO · as of the Nov 20 close · updated each morning
Moving sideways
The stock sits between its 20 and 50 day averages. It is 23% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 49). The nearest support is the Pivot S1 at $8.46, and the nearest resistance the Pivot at $8.73.
Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 5.9%/day
Key levels
$10.2052 week high+17.8%
$8.93Pivot R1+3.1%
$8.8220 day average+1.8%
$8.80Swing high (Oct 5)+1.6%
$8.73Pivot+0.8%
$8.66Last close
$8.46Pivot S1−2.3%
$8.4350 day average−2.7%
$8.11Swing low (Nov 6)−6.4%
$7.60100 day average−12.2%
$6.69200 day average−22.7%
$4.0052 week low−53.8%
Indicators
RSI (14)
48.90
Middle of its range
Neutral
MACD
0.16
Below its signal line
Bearish
Stochastic
32.1
Middle of its range
Neutral
ADX (14)
28.6
Trending up
Williams %R
-73.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
-25.9
Oversold below −100, overbought above 100
Neutral
Rate of change
+3.6%
Change over 10 sessions
Bullish
ATR (14)
$0.51
Typical daily range, 5.9% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Bounce inside a longer downtrend
Short trendBullish
Long trendBearish
MomentumStrong
StretchNormal
VolatilityLow, 9.6%/day
Key levels
$10.2052 week high+17.8%
$8.93Pivot R1+3.1%
$8.8220 day average+1.8%
$8.80Swing high (Oct 5)+1.6%
$8.73Pivot+0.8%
$8.66Last close
$8.46Pivot S1−2.3%
$8.4350 day average−2.7%
$8.11Swing low (Nov 6)−6.4%
$7.60100 day average−12.2%
$6.69200 day average−22.7%
$4.0052 week low−53.8%
Indicators
RSI (14)
60.72
Strong, overbought above 70
Neutral
MACD
0.69
Above its signal line
Bullish
Stochastic
71.8
Middle of its range
Neutral
ADX (14)
44.1
Strong uptrend
Williams %R
-41.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
95.8
Oversold below −100, overbought above 100
Neutral
Rate of change
+7.8%
Change over 10 sessions
Bullish
ATR (14)
$0.83
Typical daily range, 9.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Below
What happened before, for HBIO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how HBIO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow HBIO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for HBIOHow many large options trades hit HBIO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in HBIO in the last 90 days.
From SEC Form 4 filings by HBIO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HBIO is in one of them and how their past HBIO trades turned out.
Harvard Bioscience makes laboratory instruments, consumables, software and services used in life science research, drug discovery and preclinical testing. Its products include electroporation systems, syringe pumps, spectrophotometers, electrophysiology equipment and telemetry systems that collect data from research animals. Customers include pharmaceutical and biotechnology companies, contract research organizations, universities and government laboratories. The company is based in Holliston, Massachusetts, and sells in the United States, Europe and China.